Ken Griffin Ark Genomic Revolution ETF (De Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Citadel Advisors LLC holds 261,400 shares of ARKG stock, worth $6.34 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
261,400
Previous 385,500
32.19%
Holding current value
$6.34 Million
Previous $12.6 Million
40.57%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding ARKG
# of Institutions
316Shares Held
19.1MCall Options Held
1.49MPut Options Held
2.83M-
Main Management ETF Advisors, LLC San Francisco, CA2.69MShares$65.3 Million4.12% of portfolio
-
Morgan Stanley New York, NY1.96MShares$47.4 Million0.0% of portfolio
-
Wells Fargo & Company San Francisco, CA1.3MShares$31.6 Million0.01% of portfolio
-
Ubs Group Ag1.27MShares$30.8 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY1.13MShares$27.4 Million0.0% of portfolio